Retrospective analysis on the clinical efficacy of bevacizumab combined with FOLFOX4 in the first line treatment of metastatic colorectal cancer
ObjectivesThe addition of bevacizumab to standard chemotherapy has been improved survival outcomes in patients with metastatic colorectal cancer. However, the combination of bevacizumab with oxaliplatin-based chemotherapy as first-line treatment showed limited survival benefit. The purpose of this s...
| الحاوية / القاعدة: | Kosin Medical Journal |
|---|---|
| المؤلفون الرئيسيون: | , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Kosin University College of Medicine
2017-12-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://www.kosinmedj.org/upload/pdf/ksmc032-02-03.pdf |